Fachliteratur Gastroenterologie: Leberzirrhose

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Leber » Leberzirrhose

10. Januar 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 1887


	Artikel 1 - 20 / 37721

	Retrospective Analysis of Diagnostic and Prognostic Value of Serum Glypican-3 in Patients With HCV-Related Cirrhosis With Or Without HCC After Achieving SVR With DAA Treatment. J Gastrointest Cancer Caviglia GP, Guariglia M, Gaia S, Troshina Y, Rolle E, Saba F, Dileo E, Carucci P, Ciancio A. PMID: 41511652 [PubMed - indexed for MEDLINE]
	NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR DISEASE: ASSOCIATIONS WITH CLINICAL MARKERS AND METABOLIC ALTERATIONS. Georgian Med News Agzamkhodjaeva S, Nuritdinov N, Hamraev A, Muhamedova M, Khalimova F. PMID: 41511118 [PubMed - indexed for MEDLINE]
	Agile 3+ Index Is Independently Associated With Cardiovascular Diseases in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: Analysis of NHANES 2017-2020. Diabetes Metab Res Rev Li Y, Yang M, Yue J, Wang Z, Qi Y, Liu Q, Ma J. PMID: 41508788 [PubMed - indexed for MEDLINE]
	Associations Between Mean Arterial Pressure Thresholds and Clinical Outcomes in Decompensated Cirrhosis With Septic Shock. Am J Gastroenterol Patidar KR, Hall L, Ogola GO, Pike F, Maiwall R, Karvellas CJ, Syed F, Garrido-Trevino LF, Walker OC, Shankar N, Cullaro G, Mogri M, Iyer N, Asrani SK. PMID: 41504279 [PubMed - as supplied by publisher]
	Clinical Utility of the aMAP Risk Score for Predicting the Recurrence of Hepatic Encephalopathy After Rifaximin Treatment in Patients With Liver Cirrhosis: A Retrospective Cohort Study. Hepatol Res Takakusagi S, Kakizaki S, Yokoyama Y, Kizawa K, Marubashi K, Kosone T, Hatanaka T, Naganuma A, Tojima H, Yamazaki Y, Uraoka T, Takagi H. PMID: 41503821 [PubMed - as supplied by publisher]
	The Role of Changes in the Proportion of Fecal Short-Chain Fatty Acids on the Severity of Hepatic Encephalopathy in Cirrhosis Patients. Acta Med Indones Ferdianto MA, Kurniawan J, Maulahela H, Rumende CM, Subekti I, Rinaldi I, Shatri H, Lesmana CR. PMID: 41502202 [PubMed - indexed for MEDLINE]
	Short-Chain Fatty Acids in the Gut-Brain-Liver Axis: Implications for Hepatic Encephalopathy. Acta Med Indones Hasan I. PMID: 41502197 [PubMed - indexed for MEDLINE]
	Using Physiologically Based Pharmacokinetic Modeling and Simulations to Predict Antihypertensive Drug Doses in Cirrhotic Patients. J Clin Pharmacol Tarek M, Amin AA, Biomy R, Abdelkawy K, El-Khateeb E. PMID: 41499374 [PubMed - indexed for MEDLINE]
	Identifying subjects at risk of liver cirrhosis via a range of thresholds for common fibrosis markers: A Welsh general population-based cohort study. J Intern Med Hill TA, West J, Morling JR, Crooks CJ. PMID: 41496649 [PubMed - as supplied by publisher]
	Association of waist-to-height ratio with nonalcoholic fatty liver disease and liver fibrosis detected by vibration-controlled transient elastography: NHANES 2017-2020. Medicine (Baltimore) Xing K, Ge C, Xu L, Liu L. PMID: 41496049 [PubMed - indexed for MEDLINE]
	Unrecognised sleep disturbances in patients with cirrhosis diagnosed with a portable electroencephalogram device. BMJ Health Care Inform Uchiyama A, Kamimura H, Miida S, Maruyama H, Tonouchi T, Seol J, Kokubo T, Okura T, Watanabe Y, Kimura N, Abe H, Sakamaki A, Yokoo T, Terai S. PMID: 41494761 [PubMed - indexed for MEDLINE]
	The global economic burden of cirrhosis and other chronic liver diseases: A health-augmented macroeconomic modeling study. Hepatol Commun Zhang R, Li J, Gong Y, Mu K, Zheng J, Yin X. PMID: 41493829 [PubMed - indexed for MEDLINE]
	A multicenter multinational retrospective study of the 1-year natural history of LI-RADS 3 observations in patients with cirrhosis. Eur Radiol Asmundo L, Mercaldo N, Furtado F, Herold A, Mojtahed A, Anderson M, Bradley W, Hesami M, Peña-Trujillo V, Blandino AA, Cannella R, Vernuccio F, Srivastava S, Dighe M, Dhyani M, Sahani D, Sgrazzutti C, Brandi N, Renzulli M, Fanti S, Irun B, Brancatelli G, Vanzulli A, Sirlin C, Kambadakone AR, Catalano OA. PMID: 41493547 [PubMed - as supplied by publisher]
	SBP: Always peritonitis in decompensated cirrhosis? Case report and review of the literature. Acta Gastroenterol Belg Van Loocke Y, Kwanten W, Derdeyn J, Steinhauser T, Vonghia L, Van Dyck E, Dams K, Van der Zijden T, Hartman V, Bracke B, Francque S, Vanwolleghem T. PMID: 41493324 [PubMed - indexed for MEDLINE]
	Liver biopsy quality criteria to exclude cirrhosis in case of suspicion of porto-sinusoidal vascular disorder. JHEP Rep de Broucker C, Paradis V, Botero ML, Albuquerque M, Payancé A, Plessier A, Elkrief L, Durand F, Hillaire S, Zafar PE, Garcia Pagan JC, Rautou PE. PMID: 41492317 [PubMed]
	Association between PNPLA3 rs738409 and susceptibility to etiology-specific liver cirrhosis: a systematic review and meta-analysis. BMC Med Genomics Yang S, Cheng A. PMID: 41491174 [PubMed - indexed for MEDLINE]
	Economic evaluation of biomarker-based surveillance for Hepatocellular Carcinoma in Thai patients with Compensated Liver Cirrhosis. PLoS One Pinjaroen N, Pan-Ngum W, Poovorawan K, Wastlund D, Mueller F, Lu P, Yu RSS, Tangkijvanich P. PMID: 41490253 [PubMed - indexed for MEDLINE]
	New insights into combined immunotherapy for hepatocellular carcinoma associated with liver cirrhosis. Front Immunol Liu Y, Cong K, Li Q, Zhang D, Sheng J. PMID: 41488615 [PubMed - indexed for MEDLINE]
	Immune System and Hepatic Stellate Cells' Crosstalk in Liver Fibrosis: Pathways and Therapeutic Potential. J Immunol Res Widowati W, Sabrina AHN, Sutendi AF, Zahiroh FH, Nurjamil AM, Wargasetia TL, Nainggolan IM, Azis R, Rismani E, Vosough M. PMID: 41487942 [PubMed - indexed for MEDLINE]
	Construction and validation of a screening model for minimal hepatic encephalopathy in patients with cirrhosis: A multi-center study. Dig Liver Dis Xie C, Wang J, Meng Y, Huang Y, Zhang H, Cao B. PMID: 41484032 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 37721

Seite 1 von 1887



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung